Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipid-lowering effects of ACTH in healthy male volunteers
2005-005438-11Phase 4Completed
- Sponsor
- University of Iceland
- Start
- Dec 2005
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tetracosactide hexaacetate in dyslipidemia, sponsored by University of Iceland. Primary endpoints: Serum LDL-cholesterol concentration and Serum apolipoprotein B concentration. Started Dec 2005; status: completed.
02
Drugs
tetracosactide hexaacetate
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on 2005-005438-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005438-11.